Could a smaller dose of a COVID-19 drug work just as well?
NCT ID NCT04479358
Summary
This study tested whether a lower dose of the anti-inflammatory drug tocilizumab could help hospitalized COVID-19 patients with pneumonia recover faster. It compared the lower dose to both standard care and a higher dose of the drug. The main goal was to see if patients got better and left the hospital sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Chicago Medicine
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.